Predictive value of TGF-β1 and SMAD-7 expression at diagnosis for treatment response in low-risk myelodysplastic syndrome

Predictive value of TGF-β1 and SMAD-7 expression at diagnosis for treatment response in low-risk myelodysplastic syndrome

Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disease. Supportive treatments, such as erythropoiesis-stimulating agents (ESAs), are commonly used in patients with low-risk MDS. This study aimed to retrospectively assess the impact of bone marrow Mothers against decapentaplegic...

Full description

Saved in:
Bibliographic Details
Main Authors: Bedrettin Orhan, Hülya Öztürk Nazlıoğlu, Oğuzhan Dik, Büşra Gürbüz, Vildan Özkocaman, Tuba Ersal, İbrahim Ethem Pınar Pınar, Cumali Yalçın Yalçın, Sinem Çubukçu, Tuba Güllü Koca, Fazıl Çağrı Hunutlu, Şeyma Yavuz, Rıdvan Ali, Fahir Özkalemkaş
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2025-03-01
Series:Biomolecules & Biomedicine
Subjects:
Myelodysplastic syndrome
MDS
Mothers against decapentaplegic homolog 7
SMAD-7
Transforming Growth Factor Beta 1
TGF-β1
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/11564
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.bjbms.org/ojs/index.php/bjbms/article/view/11564

Similar Items